Sub-population of the total population of breast cancer patients. The cancerous growth in the patients belonging to this population does not reflect the receptors of HER2, estrogen, and progesterone. Breast cancers are currently being cataloged according to the presence of these receptors.
Facebook
Twitter
LinkedIn
WhatsApp
Triple Negative
To check if our service suits your case
We need to talk
Improve therapeutic outcomes, prolong life and quality of life, are our main business.
We support access to and expand cancer treatments beyond the standard of care, with the most advanced and innovative treatment options in the world, personally matching the individual cancer patient’s medical condition and with the support of top tier oncologists.
Article categories
קטגוריות המאמרים
Popular topics
Tags
Alpelisib
Amivantamab
ASCO 2025
ASCO 2026
ASCO Breast Cancer
Biological Drugs
Bispecific Antibody
Breast Cancer Clinical Trials
Breast Cancer Research
Cancer Research
Cancer Treatment
CAR T treatments
Chemotherapy
Clinical Trials
EGFR MET inhibitor
Genetic Engineering Treatments
Genomic Testing
HNSCC
Immunotherapy
innowacyjne terapie onkologiczne
Keytruda
leczenie nowotworów mózgu
Medical Cannabis
Metastatic Head and Neck Cancer
Oncology
onkologia zaawansowana
Palbociclib
Pancreatic Cancer Research
Personalized Medicine
PFS
PI3K AKT mTOR
PI3K Pathway
PIK3CA
Precision Medicine
Precision Oncology
PRMT5 Inhibitor
Progression Free Survival
RAS(ON) Inhibitor
RAS Mutation
Stage 4 Cancer
Subcutaneous Injection
Targeted Drugs
Targeted Therapy
terapia ADC
Trial-In Pharma
